Association Between Cardiovascular Risk Factors and Aortic Stenosis The CANHEART Aortic Stenosis Study

被引:190
作者
Yan, Andrew T. [1 ,2 ]
Koh, Maria [3 ]
Chan, Kelvin K. [4 ]
Guo, Helen [3 ]
Alter, David A. [3 ,5 ]
Austin, Peter C. [3 ]
Tu, Jack V. [3 ,6 ]
Wijeysundera, Harindra C. [3 ,6 ]
Ko, Dennis T. [3 ,6 ]
机构
[1] St Michaels Hosp, Terrence Donnelly Heart Ctr, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Inst Clin Evaluat Sci, Toronto, ON, Canada
[4] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[5] Univ Hlth Network, Toronto Rehabil Inst, Cardiovasc Prevent & Rehabil Program, Toronto, ON, Canada
[6] Univ Toronto, Schulich Heart Ctr, Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
aortic stenosis; epidemiology; risk factors; VALVE STENOSIS; TEMPORAL TRENDS; DISEASE; CALCIFICATION; PROGRESSION; HYPERTENSION; PREVALENCE; ONTARIO; HEALTH;
D O I
10.1016/j.jacc.2017.01.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Few longitudinal studies have delineated the association between traditional cardiovascular risk factors and development of aortic stenosis (AS). OBJECTIVES The authors examined the association between traditional cardiovascular risk factors and incident severe AS in a large, unselected elderly population. METHODS This observational cohort study used multiple linked health care population-based databases of individuals older than 65 years on April 1, 2002, without prior valvular disease, coronary artery disease, heart failure, cardiac arrhythmia, cerebrovascular disease, congenital heart disease, or admissions with cardiac symptoms. The relationship between hypertension (HTN), diabetes, dyslipidemia, and incident severe AS requiring hospitalization or surgical or interventional treatment was examined. RESULTS Among 1.12 million individuals followed for a median of 13 years, 20,995 subjects developed severe AS. Overall absolute incidence was 144 per 100,000 person-years (169 and 127 per 100,000 person-years in men and women, respectively). In cause-specific hazard models, HTN (adjusted hazard ratio [HR]: 1.71; 95% confidence interval [CI]: 1.66 to 1.76), diabetes (HR: 1.49; 95% CI: 1.44 to 1.54), and dyslipidemia (HR: 1.17; 95% CI: 1.14 to 1.21) were all significantly associated with increased risk of developing severe AS (all p < 0.001). There was a positive dose-response relationship between the number and duration of cardiac risk factors and risk of AS. In the Fine-Gray model, all 3 risk factors were independently associated with a higher incidence of AS. The population-attributable risk of AS associated with 3 cardiac risk factors was 34.4% (95% CI: 32.8 to 36.0). CONCLUSIONS HTN, diabetes, and dyslipidemia have independent and dose-response associations with incident AS in an unselected population of older individuals, and together accounted for approximately one-third of the incidence of severe AS. (C) 2017 by the American College of Cardiology Foundation.
引用
收藏
页码:1523 / 1532
页数:10
相关论文
共 38 条
[1]   Aortic valve sclerosis and aortic atherosclerosis: Different manifestations of the same disease? Insights from a population-based study [J].
Agmon, Y ;
Khandheria, BK ;
Meissner, I ;
Sicks, JD ;
O'Fallon, WM ;
Wiebers, DO ;
Whisnant, JP ;
Seward, JB ;
Tajik, AJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (03) :827-834
[2]   Introduction to the Analysis of Survival Data in the Presence of Competing Risks [J].
Austin, Peter C. ;
Lee, Douglas S. ;
Fine, Jason P. .
CIRCULATION, 2016, 133 (06) :601-609
[3]   The changing course of aortic valve disease in Scotland: temporal trends in hospitalizations and mortality and prognostic importance of aortic stenosis [J].
Berry, Colin ;
Lloyd, Suzanne M. ;
Wang, Yanzhong ;
MacDonald, Alyson ;
Ford, Ian .
EUROPEAN HEART JOURNAL, 2013, 34 (21) :1538-1547
[4]   Population-Wide Trends in Aortic Stenosis Incidence and Outcomes [J].
Bonow, Robert O. ;
Greenland, Philip .
CIRCULATION, 2015, 131 (11) :969-971
[5]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[6]   A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis [J].
Cowell, SJ ;
Newby, DE ;
Prescott, RJ ;
Bloomfield, P ;
Reid, J ;
Northridge, DB ;
Boon, NA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (23) :2389-2397
[7]   Relations of inflammation and novel risk factors to valvular calcification [J].
Fox, CS ;
Guo, CY ;
Larson, MG ;
Vasan, RS ;
Parise, H ;
O'Donnell, CJ ;
D'Agostino, RB ;
Keaney, JF ;
Benjamin, EJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (10) :1502-1505
[8]   Identifying patients with physician-diagnosed asthma in health administrative databases [J].
Gershon, Andrea S. ;
Wang, Chengning ;
Guan, Jun ;
Vasilevska-Ristovska, Jovanka ;
Cicutto, Lisa ;
To, Teresa .
CANADIAN RESPIRATORY JOURNAL, 2009, 16 (06) :183-188
[9]   Hemodynamic and Cellular Response Feedback in Calcific Aortic Valve Disease [J].
Gould, Sarah T. ;
Srigunapalan, Suthan ;
Simmons, Craig A. ;
Anseth, Kristi S. .
CIRCULATION RESEARCH, 2013, 113 (02) :186-197
[10]  
Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI [10.1016/j.jacc.2014.02.537, 10.1016/j.jacc.2014.02.536, 10.1016/j.jtcvs.2014.05.014]